Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -7.16%10.29B | 1.92%47.17B | 8.05%12.89B | -0.09%11.69B | 1.81%11.51B | -2.34%11.08B | -9.15%46.28B | -17.61%11.93B | -12.11%11.7B | -6.68%11.3B |
Cost of revenue | -7.66%6.76B | -3.34%29.06B | 1.68%7.79B | -7.56%7.24B | -8.17%6.72B | 0.78%7.32B | -22.59%30.07B | -43.93%7.66B | -23.08%7.83B | -5.14%7.32B |
Gross profit | -6.15%3.53B | 11.69%18.1B | 19.48%5.1B | 15.04%4.45B | 20.14%4.79B | -7.92%3.76B | 34.03%16.21B | 419.59%4.27B | 23.53%3.87B | -9.38%3.99B |
Operating expense | 1.08%3.64B | -0.44%14.35B | 5.09%3.78B | 0.26%3.51B | -3.35%3.46B | -3.61%3.6B | -1.99%14.42B | -0.75%3.59B | -1.05%3.5B | -3.37%3.58B |
Staff costs | ---- | -3.70%8.36B | ---- | ---- | ---- | ---- | -1.67%8.68B | ---- | ---- | ---- |
Selling and administrative expenses | ---- | 2.93%1.02B | ---- | ---- | ---- | ---- | -5.53%991M | ---- | ---- | ---- |
-Selling and marketing expense | ---- | 2.93%1.02B | ---- | ---- | ---- | ---- | -5.53%991M | ---- | ---- | ---- |
Depreciation and amortization | ---- | 2.17%376M | ---- | ---- | ---- | ---- | 6.67%368M | ---- | ---- | ---- |
-Depreciation | ---- | 2.17%376M | ---- | ---- | ---- | ---- | 6.67%368M | ---- | ---- | ---- |
Rent and land expenses | ---- | 0.28%1.06B | ---- | ---- | ---- | ---- | 2.91%1.06B | ---- | ---- | ---- |
Other operating expenses | ---- | 6.57%3.54B | ---- | ---- | ---- | ---- | -4.05%3.32B | ---- | ---- | ---- |
Operating profit | -175.32%-116M | 109.27%3.75B | 95.58%1.33B | 156.56%939M | 228.47%1.33B | -54.97%154M | 168.46%1.79B | 124.28%679M | 189.71%366M | -41.62%404M |
Net non-operating interest income (expenses) | 0.00%-60M | 15.03%-243M | 13.24%-59M | 12.68%-62M | 16.22%-62M | 17.81%-60M | -19.67%-286M | 5.56%-68M | -24.56%-71M | -29.82%-74M |
Non-operating interest income | -50.00%2M | -30.77%9M | -33.33%2M | -66.67%1M | -33.33%2M | 0.00%4M | 8.33%13M | 50.00%3M | 0.00%3M | 0.00%3M |
Non-operating interest expense | -3.13%62M | -15.72%252M | -14.08%61M | -14.86%63M | -16.88%64M | -16.88%64M | 19.12%299M | -4.05%71M | 23.33%74M | 28.33%77M |
Net investment income | -1,850.00%-35M | 33.33%4M | 0 | 0.00%2M | 0 | 100.00%2M | 50.00%3M | 0 | 100.00%2M | 0 |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 114.29%6M | -63.64%-108M | -327.27%-47M | -258.82%-61M | 268.00%42M | -223.08%-42M | 78.07%-66M | -11M | -17M | -25M |
Less:Other special charges | -114.29%-6M | 34.85%89M | 154.55%28M | ---- | ---- | 223.08%42M | -12.00%66M | --11M | --17M | --25M |
Less:Write off | ---- | --19M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Other non-operating income (expenses) | 5.56%19M | -56.52%50M | -170.00%-14M | 78.72%84M | -208.57%-38M | 38.46%18M | 310.71%115M | -55.56%20M | 280.77%47M | 683.33%35M |
Income before tax | -353.42%-185M | 122.04%3.45B | 95.14%1.2B | 177.47%899M | 272.43%1.27B | -72.96%73M | 149.63%1.55B | 119.73%617M | 166.12%324M | -45.70%341M |
Income tax | 677.78%70M | 237.84%750M | 575.76%314M | 85.59%219M | 184.93%208M | -90.72%9M | -31.69%222M | -488.24%-66M | 331.37%118M | -62.94%73M |
Net income | -504.76%-255M | 102.78%2.7B | 30.35%889M | 230.10%680M | 296.64%1.06B | -63.58%63M | 138.50%1.33B | 121.69%682M | 147.03%206M | -37.96%268M |
Net income continuous operations | -498.44%-255M | 102.71%2.7B | 30.31%890M | 230.10%680M | 296.27%1.06B | -63.01%64M | 138.53%1.33B | 121.72%683M | 146.92%206M | -37.82%268M |
Noncontrolling interests | 0 | 50.00%-1M | 0.00%-1M | 0 | 0 | 0 | 33.33%-2M | 50.00%-1M | 0 | 0 |
Net income attributable to the company | -504.76%-255M | 102.48%2.7B | 30.45%891M | 228.50%680M | 296.64%1.06B | -63.79%63M | 138.62%1.33B | 121.73%683M | 147.26%207M | -37.96%268M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -504.76%-255M | 102.48%2.7B | 30.45%891M | 228.50%680M | 296.64%1.06B | -63.79%63M | 138.62%1.33B | 121.73%683M | 147.26%207M | -37.96%268M |
Gross dividend payment | ||||||||||
Basic earnings per share | -501.50%-5.34 | 102.48%56.43 | 30.37%18.63 | 229.63%14.24 | 296.96%22.23 | -63.66%1.33 | 138.62%27.87 | 121.73%14.29 | 147.11%4.32 | -38.19%5.6 |
Diluted earnings per share | -501.50%-5.34 | 102.48%56.43 | 30.39%18.63 | 229.27%14.2247 | 296.96%22.23 | -63.66%1.33 | 138.62%27.87 | 121.73%14.2874 | 147.11%4.32 | -38.03%5.6 |
Dividend per share | ||||||||||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |